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Summary
Objective: To examine the pain experience of people with hip or knee osteoarthritis (OA), particularly changes over time and most distressing
features.
Method: Focus groups in individuals aged 40þ years with painful hip or knee OA obtained detailed descriptions of OA pain from early to late
disease. A modiﬁed Patient Generated Index (PGI) was used to assess the features of OA pain that participants found most distressing.
Content analysis was performed to examine response patterns; descriptive statistics were used to summarize PGI responses.
Results: Mean age of the 143 participants (52 hip OA; 91 knee OA) was 69.5 years (47e92 years); 60.8% were female and 93.7% Caucasian.
Participants described two distinct types of pain e a dull, aching pain, which became more constant over time, punctuated increasingly with
short episodes of a more intense, often unpredictable, emotionally draining pain. The latter, but not the former, resulted in signiﬁcant
avoidance of social and recreational activities. From PGI responses, distressing pain features were: the pain itself (particularly intense and
unpredictable pain) and the pain’s impact on mobility, mood and sleep.
Conclusions: Two distinct pain types were identiﬁed. Intermittent intense pain, particularly when unpredictable, had the greatest impact on
quality of life.
ª 2008 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.
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415Introduction
In the context of an OMERACT/OARSI initiative to develop
a new outcome measure, ‘‘total joint replacement (hip or
knee) indication’’, for use in clinical trials of osteoarthritis
(OA) disease-modifying agents, three working groups
were established to evaluate existing measures, and make
recommendations regarding the best method for measure-
ment of pain, physical function, and joint structure.
Prior qualitative work conducted by members of the OA
pain working group in the UK1,2 and Canada3 had found
416 G. A. Hawker et al.: The osteoarthritis pain experiencethat the pain experience of people living with hip and knee
OA was not adequately captured by existing measures. Fur-
thermore, evaluation of hip or knee OA pain using the com-
monly used WOMAC pain scale4 is confounded by poor
physical functioning as this scale asks patients to report
on pain experienced with ﬁve speciﬁc activities (walking,
standing, stairs, at night and at rest); as a result, WOMAC
pain and physical function subscale scores are highly corre-
lated5. Together, these studies and prior experience sug-
gested the need for a new OA pain measure.
Among people with knee OA, the presence and severity
of knee pain are recognized risk factors for disability and
radiographic progression6e8. Pain accounts for most
primary care visits for OA and for most non-steroidal
anti-inﬂammatory drug use9, and is the number one rea-
son why people with OA choose to have joint replacement
surgery10. Despite the importance of pain in OA, relatively
little is known about the quality and characteristics of OA
pain; in particular, there has been little research to assess
how pain in OA changes over time as the disease prog-
resses, or which features or combination of features in
OA pain are most important to people living with this
disease. Our incomplete understanding of the characteris-
tics and evolution of pain in OA is a barrier to appropriate
clinical care and clinical research in OA. In particular,
greater understanding of the key elements of pain in OA
that trigger changes in level of physical activity and that
drive decision-making by patients around use of various
treatment modalities, such as joint replacement surgery,
would facilitate the development of tools to assist clini-
cians in their clinical practice as well as provide much-
needed information on which to base the development of
relevant outcome measures for clinical trials of disease-
modifying agents in OA.
We conducted focus groups and one-on-one interviews
to examine the pain experience of people with hip/knee
OA from early to late disease, including those aspects of
the pain experience that were considered most distressing.
The study aimed to provide the basis for the development of
a new pain measure for OA for use in clinical practice.MethodsSTUDY PARTICIPANTSFocus groups and one-on-one interviews were conducted in six centers:
Canada (Toronto and Vancouver), the United States (North Carolina and
Texas), Australia (Sydney) and the United Kingdom (Bristol). Participants
were drawn from the community (using advertisements and ﬂyers), from
investigators’ clinical practices, and from among members of investigators’
existing OA cohorts. Those eligible to participate were: English-speaking
men and women with hip or knee OA, aged 40þ years, who responded
‘‘yes’’ to the question: ‘‘Have you experienced aching, discomfort, pain
and/or stiffness in or around a hip or knee on most days of at least 1 month
(15 or more days of the month) during the past year?’’, who had not experi-
enced an injury to the joint area within the last year, or a joint replacement of
the symptomatic joint. Conﬁrmation of OA diagnosis was based on radio-
graphic ﬁndings in the symptomatic hip or knee (OARSI grade 1þ for any
of: joint space narrowing, osteophytes, sclerosis, or subchondral cysts)10.
X-rays or X-ray reports were reviewed for eligibility by a single investigator
at each site. Anyone with concurrent rheumatoid arthritis or any other type
of inﬂammatory arthritis, ﬁbromyalgia, chronic low back pain, or another
chronic pain disorder, such as diabetic neuropathy, was excluded.
Sampling was performed to ensure approximately equal representation of
individuals with mild, moderate and severe pain, hip and knee OA, across
three age groups (40e54 years, 55e64 years and 75þ years), men and
women, and education level (high school and post-secondary education).
With respect to hip or knee pain, subjects were allocated to groups based
on their response to a 10-point Likert rating scale for usual pain experienced
in the most painful joint over the past 3 months (from 1, no pain, to 10, ex-
treme pain); participants were categorized as mild (scores of 4), moderate
(scores 5e7) or severe (scores 8e10).Ethics approval was obtained from each of the participating centers’ Insti-
tutional Research Ethics Review Board. Informed, written consent was ob-
tained from all participants.
Focus groups/interviews
Focus group format and methodology was standardized across centers.
One-on-one interviews were also conducted in Toronto using the same for-
mat. Focus groups, comprised of up to eight participants, were approximately
2.5 h in length. Each focus group or one-on-one interview used a ‘‘funnel ap-
proach’’, starting with broad open-ended questions followed by increasingly
focused questions. Initial questions were directed at obtaining detailed de-
scriptions of hip and knee pain or other sensations, exploring changes in
these characteristics over time; later questions focused on the impact of
the pain on the participants’ lives.
A modiﬁcation of Ruta et al.’s11 three-part Patient Generated Index (PGI)
was used to assess the priorities and concerns of individuals living with hip or
knee OA pain, and the varying weights and values that they attach to the
concerns. In Part 1, participants were asked to identify up to ﬁve OA pain
or symptom characteristics that they considered most distressing (e.g.,
pain is unbearable). In Part 2, participants were asked to score their level
of distress for each of the items listed in Part 1, on a 7-point Likert scale,
from 0 (the least distressing it could possibly be) to 6 (the most distressing
it could possibly be). Finally, in Part 3, participants were asked to ‘‘spend’’
10 points in total to buy relief from their distress. They were instructed to
‘‘spend’’ more points on items indicated in Part 1 that they felt were most im-
portant and less on areas they felt were less important. They were not re-
quired to ‘‘spend’’ points on all aspects of their pain, but they could not
spend more than 10 points in total. An example is shown in Fig. 1.
At the end of the focus group, participants were asked to complete a brief
questionnaire assessing their sociodemographic characteristics (age, level
of education, racial/ethnic background, and marital status), the duration of
their OA pain in the index joint (How long has it been since you ﬁrst noticed
your hip/knee?), and their level of hip/knee OA severity. The latter was as-
sessed using a valid and reliable Hip Disability and Osteoarthritis Outcome
Score12, HOOS, for hip OA, and the Knee Injury and Osteoarthritis Outcome
Score13, KOOS, for knee OA. Participants additionally completed two other
measures of pain severity: a 10-point numeric rating scale (NRS) (‘Please
rate the usual severity of your arthritis pain over the past 3 months’) with an-
chors at ‘no pain’ and ‘most extreme pain’, and a 5-point Likert scale (‘Please
indicate the usual severity of your arthritis pain over the past 3 months’) with
response options from ‘no pain’ to ‘extreme pain’. Using similar NRS and Lik-
ert scales, participants also rated their level of pain distress from ‘not at all
distressed’ to ‘extremely distressed’. Although content was standardized
across the centers, the UK group asked additional questions to explore sub-
ject’s joint pain in the context of the HOOS and KOOS14.
The questionnaire and PGI data were entered into an Access database.
Double data entry and logic checks were used to ensure data quality. The
focus groups and interviews were audio-taped and the tapes were cour-
iered to the coordinating center where they were transcribed verbatim by
a single transcriber, with one exception: the UK group transcribed their
own. Each set of transcripts was reviewed independently by a minimum
of two researchers to identify distinct themes. Themes were compared,
consensus reached and entered into N6 (QSR N6 Full Version, Release
6.0, QSR International Pty Ltd 1991e2000).
Content analysis was then performed on all coded transcripts to examine
for consistency of responses across study sites, by men vs women, across
age groups, and for individuals with hip vs knee OA15. Similarly, the coded
transcripts were examined for trends in responses over time. To do this, par-
ticipants were grouped into OA durations of less than 10 years, between 10
and 20 years, and greater than 20 years, reﬂecting approximated tertiles of
disease duration. A similar analysis was performed on the PGI responses, to
examine for differences in ‘‘most distressing’’ features of the pain over time
and by age, gender, site, and index joint (hip vs knee).
Similar to the focus group and interview analysis, PGI item responses
were grouped thematically. For each item, we calculated the frequency of re-
port by participants in PGI Part 1, the mean distress score (0e6) from PGI
Part 2, and the mean number of points allocated to each item in Part 3 of
the PGI, allowing items to be rank-ordered by: frequency, by level of distress,
and by importance.Results
Characteristics of the participants by index joint (hip or
knee) are presented in Table I. Twenty-eight focus groups
and eight interviews were conducted with 143 participants
(52 with hip OA and 91 with knee OA) in six centers. The
mean age of participants with hip and knee OA was similar,
at 69.5 years (range: 47e92 years); 48% of hip and
68% of knee participants were female and 88% and 97%,
PART 1: List Characteristics
In this part, we would like you to think of the
5 most distressing characteristics of your hip
arthritis pain or other symptoms. We want
to know what it is about the pain or other
symptoms that is most distressing to you.
Write these in the boxes on your page.
Please try to be as descriptive as possible
about the physical sensations in your hip that
you find most distressing.
If you cannot think of 5 characteristics then
just fill in as many boxes as you want.
A.
B.
C.
D.
E.
PART 2: Score Characteristics
Please score each characteristic you listed in Part 1.
The score should show how distressing you found
each characteristic over the last month. Give each
characteristic a score by circling one number, where 0
is the least distressing it could possibly be and 6 is the
most distressing it could possibly be.
the least distressing
it could possibly be
the most distressing
it could possibly be
0 1 2 3 4 5 6
0 1 2 3 4 5 6
0 1 2 3 4 5 6
0 1 2 3 4 5 6
0 1 2 3 4 5 6
PART 3: Spend Points
We want you to “spend” 10 points to show
which characteristics of your pain you feel
detract the most from your overall quality of
life. In other words, we want you to “buy” relief
from your distress.
Spend more points on characteristics where
you want more relief and less on
characteristics where you don’t want as much
relief.  You don’t have to spend points on every
characteristic. You can’t spend more than 10
points in total, but the total points you spend
must add up to 10.
Total number
of points that
you spend
must add
up to 10
Total = 10
Fig. 1. Patient Generated Index for OA pain (modiﬁed from Ruta et al.11).
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participants had high school education or less. Median self-
reported duration of symptoms in the index hip or knee was
6 years (range: 0e54 years) and 12 years (range: 1e58
years), respectively. The mean pain rating (out of 10) was
5.0 (SD 2.6) for hips and 5.5 (SD 2.4) for knees, with
mean pain distress ratings (out of 10) of 4.3 (SD 2.6) and
5.1 (SD 2.3), respectively. The mean WOMAC total and
pain subscale scores were similar for hip and knee partici-
pants, at 36.7/96 (0e81) and 7.4/20 (0e17), and 40.1/96
(0e75) and 7.8/20 (0e17), respectively. Hip participants’
HOOS scores and knee participants’ KOOS scores were
similarly well distributed across the range of possible
values.PAIN DESCRIPTORSParticipants used a wide range of terms to describe their
hip or knee pain. As shown in Table II, pain characteristics
could be broadly grouped into the following categories: de-
scriptors of pain intensity, from mild (e.g., aching, throbbing,
dull, nagging) to extremely intense pain (e.g., sharp, in-
tense, unbearable, stabbing); descriptors related to pain fre-
quency or duration (e.g., constant, persistent, ever present);
descriptors relating to the predictability of pain (e.g., hap-
pens any time, unpredictable, irregular); night pain (e.g.,
wake up, sleep disturbed, bothers sleeping); descriptors
suggestive of neuropathic pain (e.g., pins and needles,
burning pain); effect of pain on mood (e.g., debilitating, de-
pressing, distracting); and other symptoms (e.g., grating,
clicking, cramping, crunching).
Participants were also asked about the impact of their hip/
knee pain on their quality of life. By far, the greatest impactreported by participants was on their ability to do the activi-
ties they needed, or wanted to do. One participant noted,
‘‘It’s awful because you like to be active. I mean I
used to go on a treadmill and do all these kinds of
things. Can’t do it. Can’t do it anymore. And you de-
pend more on people. Like, I depend on my husband
a lot more now. You just, you know, you don’t like to
be that way.’’ (Female, aged 62 years).
Another said, ‘‘I’ve modiﬁed everything. If it hurts, I won’t do
it.’’ (Female, aged 68 years).CHANGES OVER TIMEAs expected, participants described their pain as worsen-
ing over time:
‘‘With my right knee, it started about ten or twelve
years ago. Then it was an ache, you know, uncom-
fortable. Couldn’t do stairs e well I could do them
with effort but ah, now it’s progressed.Oh, it’s got
progressively worse.’’ (Female, aged 86 years)
‘‘Intensity was not much at ﬁrst, but gradually more
and more’’ and ‘‘It’s more like a knife pain than it
was an ache before.’’ (Female, aged 62 years)
Interestingly, participants clearly described two distinct
types of pain as their OA progressed: a dull, aching, throb-
bing pain, which became more constant over time, punctu-
ated increasingly with shorter episodes of a more intense,
often unpredictable, and emotionally draining pain. The
latter, but not the former type of pain resulted in signiﬁcant
Table I
Characteristics of the focus group participants
Hips Knees
Number of participants 52 91
Number of focus groups and/or interviews 16 20
Age in years, meanSD (minemax) 68.7 9.0 (47e84) 69.9 10.3 (47e92)
Female, n (%) 25 (48.1) 62 (68.1)
Caucasian, n (%) 46 (88.4) 88 (96.7)
Education, n (%)
<High school 7/37 (18.9) 12/77 (15.6)
Completed high school 11/37 (29.7) 12/77 (15.6)
Post-secondary 19/37 (51.4) 53/77 (68.8)
Duration of OA*, median (mean, minemax) 12.0 (16.8, 1e58) (n¼ 40) 6.0 (10.2, 0e54) (n¼ 76)
NRS pain severity (1e10), meanSD (minemax) 5.0 2.6 (1e10) 5.5 2.4 (1e10) (n¼ 77)
NRS distress (1e10), meanSD (minemax) 4.3 2.6 (1e10) (n¼ 37) 5.1 2.3 (1e10)
WOMACy, meanSD (minemax)
Total (0e96) 36.7 21.5 (0e81) 40.1 19.3 (0e75.3) (n¼ 90)
Pain (0e20) 7.4 4.6 (0e17) (n¼ 51) 7.8 4.1 (0e17) (n¼ 90)
Function (0e68) 26.0 16.0 (0e58) 28.4 14.4 (0e55.3) (n¼ 90)
Stiffness (0e8) 3.5 1.7 (0e7) 4.1 1.6 (0e7) (n¼ 89)
KOOSz subscales, mean SD (minemax)
Pain N/A 73.4 21.9 (22.2e100.0) (n¼ 90)
Symptoms N/A 72.1 19.6 (25.0e100.0) (n¼ 90)
ADL N/A 73.5 22.0 (20.6e100.0) (n¼ 89)
Sports/rec N/A 54.3 37.7 (0.0e100.0) (n¼ 86)
Quality of life N/A 58.8 27.0 (0.0e100.0) (n¼ 90)
HOOSx, meanSD (minemax)
Pain 77.5 24.2 (17.5e100.0) (n¼ 51) N/A
Symptoms 74.4 23.4 (15.0e100.0) N/A
ADL 73.9 25.7 (14.7e100.0) (n¼ 51) N/A
Sports/rec 64.5 36.3 (0.0e100.0) (n¼ 50) N/A
Quality of life 69.3 26.8 (6.3e100.0) N/A
*As determined by response to question: ‘‘When did you ﬁrst notice your hip/knee?’’.
yFor worst hip joint for hip participants and for worst knee joint for knee participants.
zFor worst knee, possible range: 0 (extreme problems) to 100 (no problems).
xFor worst hip, possible range: 0 (extreme problems) to 100 (no problems).
Table II
Pain descriptors used by focus group participants
Category Example descriptors
Pain intensity Very intense/severe, quite bad, mild,
moderate, less severe, worse, better
Mild discomfort Ache, hurts, sore, nagging, throbbing,
uncomfortable, gnawing, discomfort,
tenderness, dull
Severe pain Sharp, stabbing, shooting, knife-like,
needle-like, brings tears to your eye,
excruciating, unbearable
Frequency and duration Every day, consistent in morning,
comes and goes, constant, gradual,
there all the time, background pain
Predictability Unsure when pain will come on, unsure
how long pain episode will last, pain
418 G. A. Hawker et al.: The osteoarthritis pain experienceavoidance of social and recreational activities. Although
some variability was observed, participants described these
two types of pain in the context of their OA pain progression
as follows:
Early OA e stage 1: Pain was characterized by predict-
able sharp or other pain, usually brought on by a trigger
(usually an activity, such as a sport) that eventually limited
high impact activities, such as skiing, but had relatively
little other impact.
Mid OA e stage 2: Predictable pain is increasingly
associated with unpredictable locking (knees) or other
joint symptoms. The pain becomes more constant, and
begins to affect daily activities, such as walking and climb-
ing stairs.
Advanced OA e stage 3: Constant dull/aching pain is
punctuated by short episodes of often unpredictable
intense pain that leaves one exhausted. This pattern of
intermittent, intense and often unpredictable hip or knee
pain resulted in signiﬁcant avoidance of activities, includ-
ing social and recreational activities.‘‘comes out of nowhere’’ sometimes
Night pain Sharp pain comes on at night, difﬁcult
to sleep, that’s when it really aches,
just lie awake there hurtingCOMPARISONS BY GENDER, HIP/KNEE, REGION,
RACE/ETHNICITY
Neuropathic pain Burning, pins and needles, numbness,
like sitting too close to the ﬁre
Effect on mood Paralyzing, terrorizing, want to scream,
want to cry, you get mad about the pain
Other symptoms Weakness, grinding, stiffness, seize up,
gives way, locking, unstableIn general, male participants tended to downplay their
pain and used less intense language to describe their
pain when compared with female participants. However,
signiﬁcant variability was observed. No other gender
differences were apparent. Results were generally similarfor participants with hip vs knee OA, with a few notable
exceptions: those with hip OA described, in general,
a more abrupt or rapid progression from mild to severe com-
plaints, more often used ‘intense’ descriptors (such as
Table III
Distressing pain themes identified through PGI responses
Theme Descriptors within the theme
Pain descriptors
Ache Ache, dull, discomfort, unable to ﬁnd
comfortable position, nagging pain,
sore, throbbing
Sharp pain Sharp, kniﬁng, stabbing, hurts, extreme,
worst pain, acute
419Osteoarthritis and Cartilage Vol. 16, No. 4icepick, pickaxe, spike, paralyzing), and more often made
comparisons of their pain with other extremely painful
conditions (such as childbirth, broken bones, surgery) than
did knee OA participants.
No differences were observed by study site or by race/
ethnicity, although there were insufﬁcient numbers of non-
Caucasian participants to make any deﬁnitive conclusions
about differences in the pain experience by race or
ethnicity.Burning pain Burning, ﬁery, knee on ﬁre
Constant Constant, persistent, ever present, always
there
Unpredictability Sudden, happens at any time, irregular,MOST DISTRESSING FEATURES OF OA PAIN e RESULTS
FROM PGI RESPONSES
unpredictable
Dental pain Aches like a toothache, like dentist hitting
nerve, constant toothache-like throbbing
Night pain Pain at night, wake up, sleep disturbed,
pain bothers sleeping
Pressure Pressure, tightening, crushing, heavy feeling,
weighted feeling
Radiating pain Pain travels to different areas, secondary pain
in other areas, extends from groin to knee
Pain impact
Mood Annoying, irritating, debilitating, stressful,
draining, embarrassing, depressing
Limitation
of activities
Decreased mobility, prevents enjoyment
of/participation in activities, slows me down
Triggered
by activity
Pain with activity such as walking, going
up/down stairs or bending
Weakness Weakness, tiring, joint feels weak
Use of
medications/
devices
Need for medications and ointments,
pillow between knees to relieve
pain during sleep
Fear Fear of losing ability to do things in
future, knee giving way or falling,
knowing it is incurable
Inactivity Pain/symptoms related to periods
of inactivity (e.g., sitting too long)
Other symptoms
Stiffness Stiffness at night/after activity/in morning
Cramping Cramping, muscle spasms
Clicking Clicking, cracking
Grating Grating, crunching, rubbing, grinding,
bones rub together
Numbness Pins and needles, numbing pain, numb,
no feeling at time
Unstable Loss of balance, gives way, instability,
knee collapses, feeling that it won’t
support body weight
Locking Locking of joint, unable to straighten or bend
Swelling
(knees only)
Swelling, ‘‘ﬂuid build-up’’, swollenAlthough participants were permitted to provide up to ﬁve
distressing aspects of their pain, approximately one-third
(34.4%) provided fewer than ﬁve items on the PGI. Distress-
ing features of OA hip/knee pain could be broadly grouped
into those related to the pain characteristics themselves,
those related to the impact of pain on physical functioning,
mood and sleep, and other symptoms, as shown in Table
III. Tables IV and V show the frequency with which these
common themes were cited for knee and hip participants,
respectively, as well as the mean ‘distress’ scores (/6)
and ‘points awarded to relieve this aspect of their pain’ (/10).
For both knee and hip participants, both types of pain
noted above, i.e., sharp pain and aching pain, were cited
frequently and separately as distressing (for both hips and
knees, within the top three noted distressing aspects of
pain). Among hip participants, aching discomfort was the
most frequently cited distressing feature of pain (48/52,
92.3%), while sharp pain was cited next often, by 33/52
(63.5%) participants. For knee participants, sharp pain
ranked ﬁrst in frequency (65/91, 71.4%) and aching pain
third (60/91, 65.9%). For both knee and hip participants,
mean distress scores were higher for sharp (4.2/6 for
both) than for aching pain (3.6/6 for knees, 3.3/6 for hips).
Hip or knee pain that was seen as unpredictable was also
cited as distressing, as were the impact of the pain on sleep
(due to pain at night) andmood (particularly fear for the future)
(Tables IV and V). Among the ‘other symptoms’ that partici-
pants cited as distressing, stiffness was cited most often,
ranking in frequency of reporting within the top 10 distressing
aspects of pain (26.4% of knee and 13.5% of hip partici-
pants). Cramping, clicking, locking, grating and swelling
were also cited, but with much less frequency. However,
when these symptoms were cited, they generally received
among the highest distress ratings, e.g., cramping was cited
by only three knee and one hip participants, with mean
distress scores of 4.7/6 and 5/6, respectively. The most
distressing aspects of hip/kneeOApain appeared consistent,
regardless of duration of symptoms (data not shown).
Summaries of our ﬁndings were sent to some participants
and all site coordinators and focus group moderators for
their feedback. In particular, we invited input regarding our
description of pain over time. There was general agreement
that the summaries reﬂected the discussions that had
occurred.Discussion
Despite the importance of pain in OA, the qualities, deter-
minants and consequences of OA pain have been relatively
little studied16e19. To our knowledge, this is the ﬁrst study to
examine the pain experience in OA, focusing explicitly on
the pain itself, and exploring pain related distress and
changes over time.People living with hip and knee OA identiﬁed two very
distinct types of OA pain e pain that was intermittent but
generally severe or intense, and a more persistent ‘back-
ground’ pain or aching. Participants were clearly able to
distinguish these two pain types, identifying them sepa-
rately as distressing. The more intense but less frequent
pain that comes and goes, particularly when unpredictable,
had a greater impact on quality of life than did background
aching pain. Participants described how the more intense,
unpredictable pain had negative effects on their mood, as
well as their ability to participate with conﬁdence in social
and recreational activities. Many described how they had
signiﬁcantly curtailed these activities to avoid triggering an
episode of such pain.
Participants frequently reported that OA pain had a
negative impact on sleep, including both sleep onset and
Table IV
PGI results for knee OA subjects (n¼ 91)
Rank Feature Frequency N (%) Distress (/6) meanSD (range) Points (/10) mean SD (range)
1 Sharp pain 65 (71.4) 4.2 1.4 (1e6) 2.8 2.1 (0e9)
2 Limitation of activities 63 (69.2) 4.1 1.3 (0e6) 2.6 2.1 (0e10)
3 Ache/dull 60 (65.9) 3.6 1.6 (0e6) 2.4 2.1 (0e10)
4 Triggered by activity 46 (50.5) 4.2 1.3 (1e6) 3.0 2.1 (0e10)
5 Stiffness 24 (26.4) 4.0 1.2 (2e6) 2.9 2.7 (0e10)
6 Unpredictability 23 (25.3) 3.4 1.6 (1e6) 1.4 1.5 (0e6)
7 Constant 21 (23.1) 3.9 1.5 (1e6) 2.1 1.4 (0e5)
8 Unstable 20 (22.0) 4.3 1.6 (1e6) 2.2 1.5 (0e5)
9 Night pain/impact on sleep 16 (17.6) 3.9 1.4 (1e6) 2.9 1.4 (1e5)
10 Mood 16 (17.6) 3.8 1.5 (1e6) 1.6 1.7 (0e5)
11 Swelling 14 (15.4) 3.9 1.8 (0e6) 1.6 1.2 (0e4)
12 Grating 12 (13.2) 4.3 1.3 (2e6) 1.8 1.3 (0e4)
13 Inactivity 12 (13.2) 3.5 1.2 (1e5) 2.0 1.0 (0e3)
14 Burning pain 6 (6.6) 4.2 2.3 (0e6) 3.7 1.4 (2e6)
15 Weakness 6 (6.6) 2.5 1.9 (0e5) 2.2 0.8 (1e3)
16 Fear 6 (6.6) 4.0 2.0 (1e6) 2.0 1.7 (0e4)
17 Use of medication/devices 5 (5.5) 4.2 1.3 (3e6) 1.4 1.1 (0e3)
18 Numbness 4 (4.4) 3.5 2.1 (1e6) 1.5 1.9 (0e4)
19 Locking 4 (4.4) 4.5 1.3 (3e6) 2.3 1.3 (1e4)
20 Cramping/muscle spasms 3 (3.3) 4.7 0.6 (4e5) 2.3 2.3 (1e5)
21 Clicking/cracking 3 (3.3) 3.0 0.0 (3) 2.0 2.7 (0e5)
22 Radiating pain 1 (1.1) 6 (6) 1 (1)
420 G. A. Hawker et al.: The osteoarthritis pain experiencesleep maintenance. This is consistent with prior cross-sec-
tional studies20,21 that have found that sleep disturbances
are common in people with OA, and are associated with
not only greater pain but also greater fatigue, disability
and depressed or anxious mood. In addition to pain’s ef-
fect on sleep onset and maintenance, it has also been hy-
pothesized that poor sleep exacerbates pain in people
with chronic pain disorders like OA, by decreasing pain
tolerance22,23. Despite this, few studies have examined
for the presence of concomitant primary sleep disorders,
which are common in older people, in women, and in
those who are obese e the same groups in which OA is
most prevalent. Our ﬁndings suggest the need for re-
search to better understand the relationship between
pain and sleep in OA, in particular to understand theTable V
PGI results for hip OA
Rank Feature Frequency N (%) Dist
1 Ache 48 (92.3)
2 Sharp pain 33 (63.5)
3 Limitation of activities 24 (46.2)
4 Triggered by activity 18 (34.6)
5 Mood 16 (30.8)
6 Constant pain 13 (25.0)
7 Night pain/impact on sleep 9 (17.3)
8 Triggered by inactivity 7 (13.5)
9 Stiffness 7 (13.5)
10 Burning pain 6 (11.6)
11 Radiating pain 6 (11.6)
12 Numbness 5 (9.6)
13 Unstable 4 (7.7)
14 Unpredictability 3 (5.8)
15 Clicking 2 (3.8)
16 Weakness 2 (3.8)
17 Cramping 1 (1.9)
18 Fear 1 (1.9)
19 Use of medication/devices 1 (1.9)
20 Locking 1 (1.9)
21 Grating pain 0 (0.0)
22 Swelling 0 (0.0)impact of sleep disturbances on the pain experience in
this population.
Cross-sectional population and clinical studies consis-
tently suggest that OA pain and disability are found together
with depression more frequently than would be explained by
chance8,24e27. Elucidation of the nature of this relationship
has been difﬁcult due to the fact that the symptoms of
OA, including difﬁculty sleeping, difﬁculty getting out of
bed in the morning, and lack of energy, overlap substan-
tially with those of depression28,29. Thus, it has been
suggested that the prevalence of depression in arthritis co-
horts has been over-estimated due to the overlap of somatic
symptoms in these diseases30, for which existing pain and
depression measures have not accounted. However,
consistent with the hypothesis of increased mood disorderssubjects (n¼ 52)
ress (/6) meanSD (range) Points (/10) mean SD (range)
3.3 1.5 (1e6) 3.3 3.0 (0e10)
4.2 1.5 (1e6) 2.8 2.7 (0e10)
4.6 1.4 (1e6) 2.7 2.7 (0e10)
3.7 1.7 (0e6) 4.2 3.3 (0e10)
3.3 1.4 (0e5) 3.1 2.4 (0e10)
3.5 1.8 (0e5) 3.1 2.2 (0e7)
3.4 1.7 (0e5) 2.9 2.6 (0e8)
3.3 1.5 (1e5) 1.4 1.5 (0e4)
3.0 0.6 (2e4) 1.9 1.2 (1e4)
4.0 1.7 (1e6) 2.8 1.8 (1e5)
3.5 1.6 (1e5) 1.8 1.7 (0e4)
3.6 0.9 (3e5) 2.6 1.7 (1e5)
3.3 1.7 (1e5) 1.8 0.5 (1e2)
3.3 2.5 (1e6) 0.7 0.6 (0e1)
1.5 2.1 (0e3) 6.0 5.7 (2e10)
4.0 1.4 (3e5) 2.0 1.4 (1e3)
5 (5) 1 (1)
6 (6) 0 (0)
3 (3) 0 (0)
5 (5) 1 (1)
e e
e e
421Osteoarthritis and Cartilage Vol. 16, No. 4among individuals with chronic painful OA, participants in
our study independently noted that a distressing aspect of
their pain experience was the effect on their mood. They
described a breadth of moods, from frustration and anger,
to depression. In light of studies that have consistently
shown that depression may be under-diagnosed and
under-treated among older people, our ﬁndings support
the need for strategies to increase the detection and
management of mood disorders among people living with
OA. This is particularly important because there is evidence
to suggest that depressed mood may affect OA outcomes
(e.g., adherence to therapy31) and where identiﬁed, depres-
sion is eminently treatable32.
Historically, pain associated with OA has been attributed
to local tissue injury and referred to as ‘nociceptive pain’.
For this reason, neuropathic pain symptoms are not
typically elicited in patients with OA and have not been eval-
uated scientiﬁcally. However, many participants in our study
used pain descriptors that might typically be associated with
a neuropathic pain process, such as burning and pins and
needles. In keeping with recent studies33e36, our results
suggest that patients with OA may experience pain due to
both nociceptive and neuropathic mechanisms to varying
degrees. If so, elicitation of such pain characteristics may
identify patients who might beneﬁt from neuropathic pain
medications. Further research is warranted to examine the
role of neuropathic pain in OA.
Through our use of the modiﬁed PGI, we sought to obtain
a greater understanding of the key elements of pain in OA
that individuals ﬁnd most distressing. We hypothesized
that these aspects would be those most likely to trigger
changes in level of physical activity and/or mood. In turn
these might drive decision-making by patients around use
of various treatment modalities, such as joint replacement
surgery. In this respect, we have learned that while intense
pain is distressing, that which is both intense and unpredict-
able has even greater impact on quality of life.
Strengths of our study were the inclusion of OA partici-
pants across many geographic sites, levels of education,
age and both men and women. There were, however,
some limitations. First, the majority of our study subjects
had experienced hip or knee symptoms for many years;
there were too few with symptoms lasting less than 1e2
years to comment on the pain experience of individuals
with early symptomatic OA. Second, as noted above, there
were insufﬁcient numbers of non-Caucasian individuals to
draw any conclusions about any ethnic differences in the
pain experience. Third, only English-language countries
were included. Further research could determine whether
our ﬁndings are generalizable to other groups.
In conclusion, our study is the ﬁrst to comprehensively
examine the pain experience of people living with hip and
knee OA, focusing speciﬁcally on the pain and those
features of the pain that most distressed them. Two distinct
types of pain were identiﬁed. Of these, intermittent and
intense pain, particularly when unpredictable, had the great-
est impact on quality of life. This study has laid the founda-
tion for the development of a new OA pain measure to
assist clinicians in their clinical practice as well as to serve
as an outcome measure for clinical trials of disease-
modifying agents in OA.Acknowledgements
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